Supported by research and development grants from the Danish State, Nordisk Rebalance A/S has developed Profermin®, a “food for special medical purposes” which has been registered at the Danish Veterinary and Food Administration in accordance with the Danish food legislation and the Act on foods for special medical purposes.
Profermin® is used in the dietary treatment of ulcerative colitis and irritable bowel syndrome. The effect is documented in clinical trials (see below).
According to the clinical studies, more than half of the patients with active ulcerative colitis experience an initial effect within 14 days, and a clear improvement during the first 8 weeks. A more pronounced and stable effect is usually obtained within 24 weeks of treatment.
For irritable bowel syndrome, patients usually experience an initial effect within 14 days and a clear improvement after 4-8 weeks.
Profermin® is an oat-based drink which is fermented with the lactic acid bacterium Lactobacillus plantarum 299v and added lecithin containing phosphatidylcholine.
Profermin® does not contain artificial taste and color additives or preservatives. Profermin® has a fresh acidic taste.
Foods for special medical purposes must be used under medical supervision.
The mode of effect is not known but the hypothesis is described here.